NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 1 | -97.0% | 0.00% | -100.0% |
| Q1 2020 | $586,000 | +2563.6% | 33 | 0.0% | 0.00% | -86.7% |
| Q4 2019 | $22,000 | +2100.0% | 33 | -2.9% | 0.02% | +1400.0% |
| Q3 2019 | $1,000 | 0.0% | 34 | +13.3% | 0.00% | 0.0% |
| Q2 2019 | $1,000 | 0.0% | 30 | -3.2% | 0.00% | 0.0% |
| Q1 2019 | $1,000 | -91.7% | 31 | -90.7% | 0.00% | -92.3% |
| Q3 2018 | $12,000 | -40.0% | 334 | +0.6% | 0.01% | -31.6% |
| Q2 2018 | $20,000 | +900.0% | 332 | +1228.0% | 0.02% | +850.0% |
| Q1 2018 | $2,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |